Clinicians and researchers involved in Octopus have published an article in the journal Neurology. This is one of the first scientific outputs from the trial. Octopus is the first trial in MS making use of the multi-arm multistage (MAMS) platform design. The goal is to speed up the evaluation of promising drugs against progressive MS by making the trial more efficient. The a ...
Octopus is funded by the MS Society
